B2B Timeline
Explore key milestones in the Bench to Bassinet Program, from the beginning of CHD GENES enrollment through the launch of B2B CHANGE.
2026
B2B CHANGE Grant Started
The B2B Congenital Heart disease Advancing New understanding in Genomics (CHANGE) Grant started.
2025
CHD GENES Enrollment Concludes
CHD GENES closed to new participant enrollment, and Cycle 3 enrollment was completed.
View 2025 details
- Cycle 3 enrollment was completed across nine sites.
- Fourth round of CDDRC-only Scholars.
- Return of Genetic Results, Round 2.
- Gabriella Miller Kids First X01 awarded to Bruce Gelb, MD: Expanding our understanding of the role of noncoding variation causing congenital heart defects.
- Gabriella Miller Kids First X01 awarded to Bruce Gelb, MD: Kids First X01 Long-Read Sequencing Pilot: Structural Heart and Other Defects.
- Large-scale analysis of the genetic causes of CHD identified new genetic variants associated with CHD, including variants new to the affected individual and variants inherited from a parent.
Genomic analysis of 11,555 probands identifies 60 dominant congenital heart disease genes
2024
Third Scholars Cohort and New Study Activities
The third cohort of PCGC/CDDRC Scholars began, and additional study activities expanded opportunities for ongoing research.
View 2024 details
- Third cohort of PCGC/CDDRC Scholars.
- Brain and Genes Protocol closed, allowing for ongoing analyses of de-identified data.
- Patient/parent reported Clinical Information and Adaptive Functioning study.
- Two auxiliary sites were added: University of Michigan and Children’s Healthcare of Atlanta.
2023
Second Scholars Cohort and Brain and Genes Publication
The second cohort of PCGC/CDDRC Scholars began, and the CHD Brain and Genes analysis was published.
2022
First PCGC/CDDRC Scholars Cohort
The first cohort of Pediatric Cardiac Genomics Consortium and Cardiovascular Developmental Biology Data Resource Center Scholars began.
2021
First EMR Extraction Data Received
The first electronic medical record extraction data was received from all active sites.
View 2021 details
Gabriella Miller Kids First X01 awarded to Bruce Gelb, MD: Expanding our understanding of the role of noncoding variation causing congenital heart defects.
2020
Cycle 3 Begins
Enrollment continued at remaining active sites, while the program’s focus shifted to longitudinal data collection from the existing cohort.
View Cycle 3 details
Longitudinal data sources included electronic medical records, echocardiogram imaging, the Society for Thoracic Surgery database, the National Death Index, and the MRI Core.
Remaining active sites included Columbia University, Mount Sinai, Yale University, Children’s Hospital Boston, Children’s Hospital of Los Angeles, Brigham and Women’s Hospital, and University of Utah.
2020
Cycle 2 Enrollment Completed
Cycle 2 enrollment was completed across 11 sites.
View Cycle 2 enrollment details
Gabriella Miller Kids First X01 awarded to Nicole Weaver, MD: Genetic diagnoses in a cohort of individuals with valvar pulmonary stenosis (PCGC ancillary study).
2019
Return of Genetic Results
Return of Genetic Results, Round 1.
2018
CHD Brain and Genes Enrollment Completed
Enrollment was completed with 196 participants.
View 2018 details
Gabriella Miller Kids First X01 awarded to Christine Seidman, MD: Germline Mutations in CHD.
2017
Large-Scale Analysis of Genetic Causes of CHD
A large-scale analysis identified shared genetic contributions to congenital heart disease, neurodevelopmental disabilities, and extracardiac congenital anomalies.
View related publication
2016
Cycle 2 Begins
Cincinnati Children’s Hospital Medical Center took over as the Administrative Coordinating Center and Data Management Coordinating Center.
View 2016 details
- B2B partnered with the National Institute of Child Health and Human Development to develop the CHD Brain and Genes sub-study.
- The sub-study was implemented by Jane Newburger, MD, and Eileen King, PhD, to study brain MRI and complete neurodevelopmental assessments on a subset of CHD GENES participants.
- Gabriella Miller Kids First X01 awarded to Christine Seidman, MD: Discovery of De Novo and Inherited Mutations that Cause Prevalent Birth Defects.
2015
Cycle 1 Enrollment Completed
Cycle 1 enrollment was completed across 10 sites.
View 2015 details
- Gabriella Miller Kids First X01 awarded to Christine Seidman, MD: Discovery of the Genetic Basis of Structural Heart and Other Birth Defects.
- An early paper on CHD causation identified new genes.
De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies
2010
CHD GENES Enrollment Begins
The Administrative Coordinating Center was NERI/HealthCore/Carelon, and CHD GENES enrollment began at active sites.
View 2010 active sites
Active sites included Columbia University, Mount Sinai, Yale University, Children’s Hospital Boston, Children’s Hospital of Philadelphia, Children’s Hospital of Los Angeles, Brigham and Women’s Hospital, University of Rochester, Cohen Children’s Medical Center, and University College London.
Enrolling PCGC Sites
Site participation changed across program cycles.
View Site Participation
| Site Name | Principal Investigator(s) | Participating Cycle |
|---|---|---|
| Columbia University | Wendy Chung, MD Yufeng Shen, PhD | Cycle 1-3 |
| Mount Sinai | Bruce Gelb, MD | Cycle 1-3 |
| Yale University | Martina Brueckner, MD Peter Gruber, MD | Cycle 1-3 |
| Boston Children's Hospital | Jane Newburger, MD Amy Roberts, MD | Cycle 1-3 |
| Brigham and Women's Hospital | Christine Seidman, MD | Cycle 1-3 |
| Children's Hospital of Philadelphia | Betsy Goldmuntz, MD | Cycle 1-2 |
| University of Utah | Marti Tristani, MD | Cycle 2-3 |
| Children's Hospital of Los Angeles | Rick Kim, MD Shuo Wang, MD | Cycle 1-3 |
| University of Rochester | George Porter, MD | Cycle 2 |
| Gladstone / University of California, San Francisco | Deepak Srivastava, MD | Cycle 2 |
| Stanford University | Dan Bernstein, MD | Cycle 2 |
| Cohen Children's Medical Center | Dorota Gruber, PhD | Cycle 1 |
| University College London | John Deanfield, MD Alessandro Giardini, MD | Cycle 1 |